| Literature DB >> 29881490 |
Mahdi Aithoussa1,2, Noureddine Atmani1,2, Reda Mounir1,2, Younes Moutakiallah1,2, Mehdi Bamous1,2, Abdessamad Abdou1,2, Fouad Nya1,2, Anis Seghrouchni1,2, Siham Bellouize1,2, Mohamed Drissi2,3, Mostafa Elouennass2,4, Youssef Elbekkali1,2, Abdelatif Boulahya1,2.
Abstract
INTRODUCTION: Cardiac surgery is frequently needed during active phase of infective endocarditis (IE). The purpose of this study was to analyze the immediate and late results and determine the risk factors for death.Entities:
Keywords: Infective endocarditis; active phase; valvular surgery
Mesh:
Year: 2017 PMID: 29881490 PMCID: PMC5989182 DOI: 10.11604/pamj.2017.28.245.13518
Source DB: PubMed Journal: Pan Afr Med J
Demographic data
| Variables | Mean ± SD / n(%) |
|---|---|
|
| 40.5 ± 12.5 |
|
| |
| Male n (%) | 75 (74.3%) |
| Female n (%) | 26 (25.7%) |
|
| 23.44 ± 8.71 |
|
| 4 (3.96%) |
|
| 8 (7.9%) |
|
| 18 (17.8%) |
|
| |
| III- IV | 81 (80.2%) |
| CTI | 0.58±0.64 |
|
| 24(23.8%) |
|
| |
| Brain | 6 (5.94%) |
| Spleen | 3 (2.97%) |
| Hepatic | 1 (0.9%) |
| Renal | 3 (2.97%) |
| Coronary | 2 (1.98%) |
| Mycoticanevrysm | 2 (1.98%) |
|
| 20 (19.80%) |
|
| 5.76±3.94 |
|
| 12(11.8%) |
|
| 53.53 ± 21.12 |
|
| |
| Mitral | 30 (29.7%) |
| Aortic | 47 (46.7%) |
| Mitral + aortic | 24 (23.7%) |
|
| 16 (15.8%) |
|
| 85 (8.49%) |
BMI: body mass index; CTI: cardiothoracic index; NVE: native valve endocarditis; PVE: prosthetic valve endocarditis; SPAP: Systolic pulmonary arterial pressure
Operative data
| Variable | Mean ± SD / n(%) |
|---|---|
| No-elective surgery n(%) | 25 (2.48%) |
| CPB time (min) | 117.8± 58,3 |
| Aortic cross clamp time (min) | 78,89 ± 41.59 |
| Mechanical ventilation time (hours) | 11(5-20.5) |
| ICU stay (hours) | 48(44-72) |
| Post-operative hospital stay (days) | 14± 11.2 |
| LOS: n(%) | 23 (22.9%) |
| Post-operative renal insufficiency n(%) | 25(24.8%) |
| Reexploration for bleeding n(%) | 6(5.9%) |
| Sepsis n(%) | 8(7.9%) |
| Digestive complications n(%) | 5(4.9%) |
| MOF: n(%) | 15(14.9%) |
| In-hospital mortality n(%) | 18 (17.8%) |
CPB: cardiopulmonary bypass; ICU: intensive care unit; LOS: Low output syndrome; MOF: Multiorgan failure
Univariate analysis
| Variable | OR | IC à 95% | P |
|---|---|---|---|
| RI | 0.34 | 0.11 - 1.04 | 0.05 |
| CHF | 0.19 | 0.07 - 0.56 | 0.003 |
| Left BBB | 0.46 | 0.21 - 1 | 0.05 |
| Euroscore | 0.78 | 0.68 - 0.9 | 0.001 |
| Age | 0.97 | 0.93 - 1.02 | 0.3 |
| Sexe | 2.14 | 0.73 - 6,2 | 0.16 |
| LV | 0.61 | 0.14 - 2.5 | 0.5 |
| CPB time | 0.98 | 0.97 - 0.99 | 0.001 |
| Mechanical VA | 0.97 | 0.96 - 0.99 | 0.011 |
| ICU stay | 0.99 | 0.98 - 1 | 0.011 |
| PVE | 1.6 | 0.89 - 3.1 | 0.1 |
BBB: bundle branch block; CHF: congestive heart failure; CPB: cardiopulmonary bypass; ICU: intensive care unit; LV: left ventricle; PVE: prosthetic valve endocarditis; RI: renal insufficiency
Multivariate analysis
| Variable | OR | IC à 95% | P |
|---|---|---|---|
| CHF | 0.57 | 0.06-5.02 | 0.018 |
| Euroscore | 1 | 0.77-1.4 | 0.008 |
| CPB time | 0.97 | 0.94-1 | 0.0001 |
| ICU time | 1 | 0.99-1.01 | 0.0001 |
| RI | 0.11 | 0.02-0.55 | 0.008 |
CHF: congestive heart failure; CPB: cardiopulmonary bypass; ICU: intensive care unit; RI: renal insufficiency